CYCLOSPORIN A AFFECTS THE PROLIFERATION PROCESS IN NORMAL HUMAN DERMAL FIBROBLASTS

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Cyclosporin A (CsA) is an immunosuppressant used for transplants and inflammatory skin conditions.
• Serious CsA side effects like skin cancer may stem from latent proliferation.
• The molecular signaling of CsA in epidermal tissue remains poorly understood.

Purpose of the Study:

• To investigate the influence of Cyclosporin A on proliferation in normal human dermal fibroblasts.
• To identify molecular signaling pathways affected by CsA in dermal cells.

Main Methods:

• Human dermal fibroblasts were cultured and treated with Cyclosporin A.
• Cell survival and proliferation assays were conducted.
• Gene expression profiling was performed using microarrays (HGU-133A_2.0) followed by statistical analysis.

Main Results:

• Cyclosporin A significantly altered the expression of 66 mRNAs related to cell cycle and transcription regulation.
• Key genes like MKI67, CDK1, and FOSL1 showed altered expression patterns.
• Specific temporal regulation of FOSL1 and HMOX1 expression by CsA was observed.

Conclusions:

• Cyclosporin A significantly affects normal human dermal fibroblast proliferation.
• CsA modulates gene expression related to cell cycle and transcription.
• These findings provide insights into CsA's molecular mechanisms and potential side effects.